HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Harikesh Kalonia Selected Research

Quinolinic Acid

11/2012Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats.
4/2011Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
3/2011Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
2/2011Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
8/2010Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
3/2010Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
12/2009Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.
11/2009Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Harikesh Kalonia Research Topics

Disease

16Body Weight (Weight, Body)
01/2013 - 06/2007
11Huntington Disease (Huntington's Disease)
06/2013 - 11/2009
6Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013 - 03/2010
2Fatigue
01/2012 - 01/2012
1Necrosis
06/2013
1Inflammation
08/2012
1Neuralgia (Stump Neuralgia)
09/2011
1Hyperalgesia
09/2011
1Ataxia (Dyssynergia)
12/2009

Drug/Important Bio-Agent (IBA)

9CatalaseIBA
01/2013 - 01/2009
8Quinolinic AcidIBA
11/2012 - 11/2009
6Glutathione (Reduced Glutathione)IBA
01/2013 - 11/2009
6salicylhydroxamic acid (SHAM)IBA
11/2012 - 12/2009
53-nitropropionic acidIBA
01/2012 - 11/2009
4Superoxide DismutaseIBA
05/2010 - 01/2009
3Interleukin-6 (Interleukin 6)IBA
06/2013 - 09/2011
3licofeloneIBA
01/2012 - 03/2011
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 11/2009
3EnzymesIBA
03/2011 - 11/2009
2malonic acid (malonate)IBA
06/2013 - 05/2010
2sesamolIBA
01/2013 - 07/2010
2Minocycline (Cyclops)FDA LinkGeneric
11/2012 - 01/2012
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2012 - 01/2012
1rofecoxib (Vioxx)FDA Link
06/2013
1Buspirone (Buspar)FDA LinkGeneric
01/2013
1CytokinesIBA
11/2012
1Oxidopamine (6 Hydroxydopamine)IBA
08/2012
1Carbon MonoxideIBA
08/2012
1Prostaglandins F (PGF)IBA
09/2011
1Lipoxygenase (Lipoxygenase-1)IBA
09/2011
1Caspase 3 (Caspase-3)IBA
09/2011
1MelatoninIBA
09/2011
1Cyclooxygenase InhibitorsIBA
04/2011
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
02/2011
1Diltiazem (Cardizem)FDA LinkGeneric
02/2011
1Verapamil (Calan)FDA LinkGeneric
02/2011
1Neuroprotective AgentsIBA
01/2011
1Tacrolimus (Prograf)FDA LinkGeneric
10/2010
1pioglitazone (Actos)FDA Link
08/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2010
1Antidepressive Agents (Antidepressants)IBA
05/2010
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2009
1Glutathione Disulfide (GSSG)FDA LinkGeneric
12/2009
1lycopeneIBA
11/2009
1Dizocilpine Maleate (Dizocilpine)IBA
11/2009
1Diazepam (Valium)FDA LinkGeneric
06/2007